GALLANT: Metronomic Gemcitabine, Doxorubicin, Docetaxel and Nivolumab for Advanced Sarcoma

Name: GALLANT: Metronomic Gemcitabine, Doxorubicin, Docetaxel and Nivolumab for Advanced Sarcoma
License: Public Domain

Sarcoma Oncology Research Center, LLC · clinicaltrials

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

sarcoma

ClinicalTrials.gov Show glossary Search for terms Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.

Record · ID 18591 · SHA-256 17c3746fc8cd5ac2
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.